Skip to main content

Medicare beneficiaries at high risk for severe COVID-19 received less treatment. A new study examines why

By Fortune  
   February 05, 2024

A recently published study in the JAMA Health Forum of a cross-section of patients enrolled in Medicare in 2022, found that those at the highest risk for severe COVID-19 infection received COVID-19 therapy less often than those with the least risk.

Full story


Get the latest on healthcare leadership in your inbox.